District Court, District of New Mexico, 1995 U.S
Consult with your prescribing clinician for the right transition plan
Understanding that plateaus are temporary and that continued adherence to treatment will eventually lead to resumed progress helps maintain motivation and commitment
Users with significant weight loss goals, metabolic syndrome, or type 2 diabetes that has not responded adequately to GLP-1 monotherapy may benefit from the additional GIP pathway activation
While compounding is legal and part of the health care system, pharmacists who do it have a lot of rules to follow
[1] [6] Common dosing protocols in clinical studies have ranged from 600 mg to 1,400 mg per session, administered two to three times per week, though higher or lower doses may be used depending on individual needs